Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 16;11(9):e053095.
doi: 10.1136/bmjopen-2021-053095.

Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK: a cross-sectional population survey

Harriet D Quinn-Scoggins  1 , Rebecca Cannings-John  2 , Yvonne Moriarty  2 , Victoria Whitelock  3 , Katriina L Whitaker  4 , Detelina Grozeva  2 , Jacqueline Hughes  2 , Julia Townson  2 , Kirstie Osborne  3 , Mark Goddard  2 , Grace M McCutchan  5 , Jo Waller  6 , Michael Robling  2   7 , Julie Hepburn  8 , Graham Moore  7 , Ardiana Gjini  9   10 , Kate Brain  11
Affiliations

Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK: a cross-sectional population survey

Harriet D Quinn-Scoggins et al. BMJ Open. .

Abstract

Objectives: To understand self-reported potential cancer symptom help-seeking behaviours and attitudes during the first 6 months (March-August 2020) of the UK COVID-19 pandemic.

Design: UK population-based survey conducted during August and September 2020. Correlates of help-seeking behaviour were modelled using logistic regression in participants reporting potential cancer symptoms during the previous 6 months. Qualitative telephone interviews with a purposeful subsample of participants, analysed thematically.

Setting: Online UK wide survey.

Participants: 7543 adults recruited via Cancer Research UK online panel provider (Dynata) and HealthWise Wales (a national register of 'research ready' participants) supplemented with social media (Facebook and Twitter) recruitment. 30 participants were also interviewed.

Main outcome measures: Survey measures included experiences of 15 potential cancer symptoms, help-seeking behaviour, barriers and prompts to help-seeking.

Results: Of 3025 (40.1%) participants who experienced a potential cancer symptom, 44.8% (1355/3025) had not contacted their general practitioner (GP). Odds of help-seeking were higher among participants with disability (adjusted OR (aOR)=1.38, 95% CI 1.11 to 1.71) and who experienced more symptoms (aOR=1.68, 95% CI 1.56 to 1.82), and lower among those who perceived COVID-19 as the cause of symptom(s) (aOR=0.36, 95% CI 0.25 to 0.52). Barriers included worries about wasting the doctor's time (1158/7543, 15.4%), putting strain on healthcare services (945, 12.6%) and not wanting to make a fuss (907, 12.0%). Interviewees reported reluctance to contact the GP due to concerns about COVID-19 and fear of attending hospitals, and described putting their health concerns on hold.

Conclusions: Many people avoided healthcare services despite experiencing potential cancer symptoms during the COVID-19 pandemic. Alongside current help-seeking campaigns, well-timed and appropriate nationally coordinated campaigns should signal that services are open safely for those with unusual or persistent symptoms.

Trial registration number: ISRCTN17782018.

Keywords: COVID-19; oncology; preventive medicine; primary care; public health; statistics & research methods.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Recruitment flow chart. CABS, COVID-19 Health and Help-Seeking Behaviour Study; COVID-CAM, Cancer Research UK’s COVID-19 Cancer Awareness Measure; DOB, date of birth.
See this image and copyright information in PMC

References

    1. Cancer Research UK . Cancer mortality for all cancers combined. CancerStats, 2019. Available: http://www.cancerresearchuk.org/cancer-info/cancerstats/mortality/all-ca... [Accessed 21 Jan 2021].
    1. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019;144:1941–53. 10.1002/ijc.31937 - DOI - PubMed
    1. Swann R, McPhail S, Witt J, et al. Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit. Br J Gen Pract 2018;68:e63 LP–72. 10.3399/bjgp17X694169 - DOI - PMC - PubMed
    1. Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 2015;112:S92–107. 10.1038/bjc.2015.48 - DOI - PMC - PubMed
    1. Koo MM, Swann R, McPhail S, et al. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol 2020;21:73–9. 10.1016/S1470-2045(19)30595-9 - DOI - PMC - PubMed

Publication types

Associated data